Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs57733852 | chr14:74484111 | T/C | 3.72E-7 | 178 | 25.28 | 28.38 | 7.4 | KM Plot |
PCPG | rs577834 | chr10:99699045 | C/T | 5.45E-5 | 173 | 24.52 | 27.33 | 19.03 | KM Plot |
PCPG | rs5781474 | chr1:227367483 | GA/GAA | 0.000144 | 175 | 25.17 | 34.17 | 2.3 | KM Plot |
PCPG | rs57839759 | chr12:53500060 | ATGTG/A | 1.19E-10 | 175 | 25 | 27.08 | 3.05 | KM Plot |
PCPG | rs57870697 | chr12:56752874 | A/G | 9.85E-8 | 177 | 25.35 | 27.33 | 9.98 | KM Plot |
PCPG | rs57931052 | chr7:158706680 | C/T | 0 | 176 | 25.6 | 23.43 | 3.17 | KM Plot |
PCPG | rs57940434 | chr16:89975496 | G/A | 0.00018 | 173 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs57986258 | chr2:236192499 | G/A | 3.73E-7 | 170 | 27.2 | 24.7 | 3.07 | KM Plot |
PCPG | rs5802846 | chr13:37506932 | T/TAAAAC | 4.06E-5 | 177 | 56.35 | 24.23 | 25.7 | KM Plot |
PCPG | rs58031143 | chr17:25586056 | T/C | 1.31E-5 | 177 | 25.28 | 27.33 | 13.53 | KM Plot |
PCPG | rs58036138 | chr12:21640745 | C/T | 2.72E-8 | 174 | 25.4 | 25.67 | 2.28 | KM Plot |
PCPG | rs58126826 | chr2:176173057 | C/T | 0.000115 | 178 | 25.28 | 28.95 | 6.62 | KM Plot |
PCPG | rs5815491 | chr16:8763230 | A/AC | 0 | 178 | 25.47 | 23.53 | 3.17 | KM Plot |
PCPG | rs58204468 | chr2:61498662 | T/A | 8.86E-5 | 174 | 20.47 | 30.63 | 10.3 | KM Plot |
PCPG | rs58241826 | chr13:64098367 | C/T | 9.78E-8 | 175 | 25.87 | 21.55 | 18.13 | KM Plot |